Liposomes loaded with antibiotics eliminate intracellular bacteria in a colorectal cancer model, unleashing antitumor T cell immunity.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Wang, M. L. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01957-8 (2023).
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A. & Moon, J. J. Nat. Mater. 16, 489–496 (2017).
Zamora, A. E., Crawford, J. C. & Thomas, P. G. J. Immunol. 200, 392–399 (2018).
Galeano Niño, J. L. et al. Nature 611, 810–817 (2022).
Kalaora, S. et al. Nature 592, 138–143 (2021).
Naghavian, R. et al. Nature 617, 807–817 (2023).
Nejman, D. et al. Science 368, 973–980 (2020).
Seynhaeve, A. L. B., Amin, M., Haemmerich, D., van Rhoon, G. C. & Ten Hagen, T. L. M. Adv. Drug Deliv. Rev. 163-164, 125–144 (2020).
Riquelme, E. et al. Cell 178, 795–806.e12 (2019).
J.J.M. declares financial interests for board membership, as a paid consultant, for research funding, and/or as an equity holder in EVOQ Therapeutics and Saros Therapeutics.
About this article
Cite this article
Han, K., Cho, Y.S. & Moon, J.J. Antibiotic nanoparticles boost antitumor immunity. Nat Biotechnol (2023). https://doi.org/10.1038/s41587-023-02046-6